GOSS CIK: 1728117

Gossamer Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
0
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−216
FY22:
−219
FY23:
−184
FY24:
−59.9
FY25:
−171
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
−40.0
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−234
FY22:
−229
FY23:
−180
FY24:
−55.6
FY25:
−170
(positive)
Change from FY21 to FY25
millions USD
FY21:
−234
FY22:
−229
FY23:
−180
FY24:
−56.5
FY25:
−170

All amounts in millions USD Data sources:SEC EDGARTwelve Data